You are here: Industry Insights > Moderna

News List

Moderna initiates Phase III trial of COVID-19 vaccine candidate europeanpharmaceuticalreview
August 04, 2020
The first patients have been dosed in Moderna’s Phase III clinical trial of its mRNA vaccine candidate to protect against COVID-19.
Moderna Announces Start of Phase 3 COVE Study of mRNA Vaccine against COVID-19 americanpharmaceuticalreview
July 28, 2020
Moderna has announced that the Phase 3 study of its mRNA vaccine candidate (mRNA-1273) against COVID-19 has begun dosing participants.
Moderna to get additional $472m from BARDA for Covid-19 vaccine pharmaceutical-technology
July 28, 2020
Moderna and the US Biomedical Advanced Research and Development Authority (BARDA) have updated their contract for an additional funding commitment of up to $472m.
U.S. Invests $472mn More in Moderna contractpharma
July 28, 2020
Expansion of BARDA deal supports mRNA-1273 clinical development plan including 30,000 participant Phase 3 COVE study conducted in collaboration with NIH.
Moderna begins Phase 3 trials of its COVID-19 vaccine candidate expresspharma
July 28, 2020
The randomised, placebo-controlled trial is expected to include approximately 30,000 participants in the US.
Moderna expects to start late-stage COVID-19 vaccine trial on July 27 expresspharma
July 16, 2020
Moderna said it will conduct the trial at 87 study locations, all in the U.S.
Moderna Phase 1 results show coronavirus vaccine safe, induces immune response expresspharma
July 16, 2020
Volunteers who got two doses of the vaccine had high levels of virus-killing antibodies that exceeded the average levels seen in people who had recovered from COVID-19: Moderna's research team.
Moderna and ROVI Ink Fill-Finish Deal contractpharma
July 14, 2020
Collaboration for fill-finish manufacturing of Moderna’s COVID-19 vaccine candidate.
Moderna teams up with ROVI to provide Covid-19 vaccine outside US pharmaceutical-technology
July 13, 2020
US-based biotechnology firm Moderna has partnered with European pharmaceutical company Laboratorios Farmacéuticos Rovi (ROVI) for finish-fill manufacturing of its Covid-19 vaccine candidate, mRNA-1273.
Moderna signs deal with Spain’s Rovi to supply potential COVID-19 vaccine outside US expresspharma
July 10, 2020
Moderna’s vaccine was among the first to be tested in humans in the United States and was found to produce protective antibodies in a small group of healthy volunteers in May.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 22 23 Next page